Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy
Epilepsia · 2024
DOI: 10.1111/epi.18133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Leah J Blank und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology, Division of Health Outcomes and Knowledge Translation Research, Icahn School of Medicine at Mount Sinai, New York, New York…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Patient Acceptance of Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, American Epilepsy Society, National Institute on Aging.
Abstract (Originalsprache)
Objective
Epilepsy is primarily treated with antiseizure medications (ASMs). The recommendations for first ASM in newly diagnosed epilepsy are inconsistently followed, and we sought to examine whether nonrecommended first ASM was associated with acute care utilization.
Methods
We conducted a retrospective cohort study of adults (≥18 years old) with newly diagnosed epilepsy (identified using validated epilepsy/convulsion International Classification of Diseases, Clinical Modification codes) in 2015–2019, sampled from Marketscan's Commercial and Medicare Databases. Exposure of interest was receipt of a non‐guideline‐recommended ASM, and the primary outcome was acute care utilization (an emergency department visit or hospitalization after the first ASM claim). Descriptive statistics characterized covariates, and multivariable negative binominal regression models were built adjusting for age, sex, Elixhauser Comorbidity Index, comorbid neurologic disease (e.g., stroke), and ASM polypharmacy.
Results
Approximately 14 681 people with new epilepsy were prescribed an ASM within 1 year. The three most prescribed medications were levetiracetam (54%, n = 7912), gabapentin (10%, n = 1462), and topiramate (7%, n = 1022). Approximately 4% ( n = 648) were prescribed an ASM that should be avoided, and ~74% of people with new epilepsy had an acute care visit during the follow‐up period. Mean number of acute care visits during follow‐up was 3.34 for “recommended” ASMs and 4.42 for ASMs that “should be avoided.” Prescription of a recommended/neutral ASM as compared to an ASM that should be avoided was associated with reduced likelihood of acute care utilization (incidence rate ratio [IRR] = .85, 95% confidence interval [CI] = .77–.94). The recommended/neutral category of ASMs was not statistically significantly associated with seizure‐ or epilepsy‐specific acute care utilization (IRR = .93, 95% CI = .79–1.09). Significance Adults with new epilepsy are frequent users of acute care. There remain a proportion of persons with epilepsy prescribed ASMs that guidelines suggest avoiding, and these ASMs are associated with increased likelihood of emergency department visit or hospitalization. These findings reinforce the importance of optimizing the choice of first ASM in epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Neurology, Division of Health Outcomes and Knowledge Translation Research, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Departments of Population Health and Policy, Institute for Healthcare Delivery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Departments of Neurology, Epidemiology, Neurosurgery and the Gertrude H. Sergievsky Center, Columbia University, New York, New York, USA.
- Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Geriatrics Research, Education, and Clinical Center, Birmingham Veterans Affairs Health Care System, Birmingham, Alabama, USA.
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Leah J Blank, Parul Agarwal, Churl-Su Kwon, Nathalie Jetté
Förderung
- NIA NIH HHS
- American Epilepsy Society
- National Institute on Aging
Zitieren
APA
Blank, L. J., Agarwal, P., Kwon, C. S., Boockvar, K., & Jetté, N. (2024). Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy. Epilepsia. https://doi.org/10.1111/epi.18133
Vancouver
Blank LJ, Agarwal P, Kwon CS, Boockvar K, Jetté N. Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy. Epilepsia. 2024. doi:10.1111/epi.18133
BibTeX
@article{Blank2024,
author = {Blank, Leah J and Agarwal, Parul and Kwon, Churl-Su and Boockvar, Kenneth and Jetté, Nathalie},
title = {Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.18133}
}
EUVIMED